Related Experiment Video
Updated: Jan 15, 2026

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
Severe Macular Atrophy in an Infant With Neuromuscular Oculoauditory Syndrome
Justin S Yun1, Marcus H Yamamoto2,3, Alejandro I Marin2
1David Geffen School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii.
Abstract:
Pathogenic variants in DEAH-box helicase 16 (DHX16) that are critical regulators of mRNA metabolism have been linked to neuromuscular oculoauditory syndrome (NMOAS), a rare disorder characterized by sensorineural hearing loss, neuromuscular deficits, and retinal abnormalities. This report covers a rare case of a 6-month-old girl with congenital SNHL, global hypotonia, and distinctive bilateral retinal dystrophy. Eye exam revealed severe macular atrophy with peripheral pigmentary changes. Spectral-domain optical coherence tomography confirmed outer retinal thinning and disruption of the photoreceptor integrity. Whole trio genome sequencing identified a de novo heterozygous variant in DHX16, c.1360C>T (p.Arg454Trp), previously described in only one patient, and classified as likely pathogenic. This case expands the understanding of DHX16-associated NMOAS and the importance of comprehensive ophthalmological assessment and genetic analysis in infants with multisystem involvement.
Insights
Pathogenic variants in the DHX16 gene cause neuromuscular oculoauditory syndrome (NMOAS), a rare condition. This case highlights a new DHX16 variant in an infant with hearing loss, hypotonia, and retinal dystrophy, emphasizing genetic testing.
Area of Science:
- Genetics
- Ophthalmology
- Neurology
Background:
- Neuromuscular oculoauditory syndrome (NMOAS) is a rare genetic disorder.
- It is characterized by sensorineural hearing loss, neuromuscular deficits, and retinal abnormalities.
- Pathogenic variants in the DEAH-box helicase 16 (DHX16) gene are implicated in NMOAS.
Purpose of the Study:
- To report a rare case of NMOAS in an infant.
- To describe the clinical and genetic findings.
- To expand the understanding of DHX16-associated NMOAS.
Main Methods:
- Clinical examination including ophthalmological assessment.
- Spectral-domain optical coherence tomography (SD-OCT).
- Whole trio genome sequencing.
Main Results:
- A 6-month-old girl presented with congenital sensorineural hearing loss, global hypotonia, and bilateral retinal dystrophy.
- Ophthalmological findings included severe macular atrophy and peripheral pigmentary changes.
- Whole trio genome sequencing identified a likely pathogenic de novo heterozygous DHX16 variant (c.1360C>T, p.Arg454Trp).
Conclusions:
- This case expands the phenotypic spectrum of DHX16-associated NMOAS.
- Comprehensive ophthalmological assessment and genetic analysis are crucial for diagnosing infants with multisystem involvement.
- The identified DHX16 variant, previously reported in only one patient, is likely pathogenic.
Related Concept Videos
Visual Agnosia
Prosopagnosia
Unrenewable Cells
Photoreceptors
The retina is composed of several layers and contains specialized cells called photoreceptors. The photoreceptors (rods and cones) change their membrane potential when stimulated by light energy. There are two types of photoreceptors—rods and cones—which differ in the shape of...
Glaucoma: Overview

